Postpartum Extended-Release Buprenorphine Tissue Necrosis

Department of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, and Family Medicine, Exodus Healthcare Network, Magna, Utah.

Corresponding author: Theresa Kurtz, MD, Department of Obstetrics & Gynecology, University of Utah Health, Salt Lake City UT; [email protected].

Funding provided by REDCap grant UM1TR004409 NCATS/NIH.

Financial Disclosure Marcela C Smid and Jasmin E. Charles serve as medical consultants for Gilead Science Inc for hepatitis C treatment in pregnancy and RH Capital. Marcela C Smid's institution receives research funding from Gilead Science Inc and Alydia/Organon. She receives research funding from NIH NIDA and CDC. The other authors did not report any potential conflicts of interest.

The authors thank Hannah Wilcox, MD, and Josh Bleicher, MD, from the surgery team and Drew Ferguson, MD, from the pathology team for their assistance in preparation of the manuscript.

Presented at the American College of Academic Addiction Medicine’s conference, April 11–12, 2023, National Harbor, Maryland.

Each author has confirmed compliance with the journal's requirements for authorship.

Peer reviews and author correspondence are available at https://links.lww.com/AOG/D457.

Comments (0)

No login
gif